Fukushima, Japan

Hiroaki Kodama

This inventor holds 1 USPTO granted patent. Top assignee: Zenogen Pharma Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroaki Kodama. Retrieved from https://idiyas.com/inventor/hiroaki-kodama-vhsty67y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroaki Kodama: Innovator in Immunostimulation

Introduction

Hiroaki Kodama is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of immunostimulation through his innovative research and development.

Latest Patents

Kodama holds a patent for an immunostimulator, pharmaceutical composition, and food or beverage. This patent includes an immunostimulator that contains chitosan and/or a chitosan derivative, each having a weight-average molecular weight of 10k to 1000k, along with an anionic surfactant. The immunostimulator is presented in particulate form. Additionally, the patent covers a pharmaceutical composition and an alimentary product, each containing the immunostimulator as an active ingredient. He has 1 patent to his name.

Career Highlights

Hiroaki Kodama is associated with Zenogen Pharma Co., Ltd., where he continues to advance his research in immunostimulation. His work has the potential to impact various sectors, including pharmaceuticals and nutrition.

Collaborations

Kodama collaborates with Etsuya Okamoto, contributing to the innovative projects at Zenogen Pharma Co., Ltd.

Conclusion

Hiroaki Kodama's work in immunostimulation exemplifies the importance of innovation in healthcare. His contributions are paving the way for new therapeutic options and enhancing our understanding of immunological responses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…